AG2R LA Mondiale Gestion D Actifs Has $1.53 Million Stake in IQVIA Holdings Inc. $IQV

Key Points

• AG2R LA Mondiale Gestion D Actifs raised its stake in IQVIA Holdings Inc. by 23.3% in Q2, now holding 9,675 shares valued at approximately $1.53 million.
• Investors like Canada Pension Plan Investment Board and JPMorgan Chase & Co. also increased their holdings significantly, reflecting a strong interest in IQVIA stock among institutional investors.
• Analysts have shown optimism with Multiple price target increases for IQVIA, with price targets now reaching as high as $235 and a consensus rating of "Moderate Buy."

AG2R LA Mondiale Gestion D Actifs increased its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 23.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,675 shares of the medical research company's stock after buying an additional 1,827 shares during the period. AG2R LA Mondiale Gestion D Actifs' holdings in IQVIA were worth $1,525,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Canada Pension Plan Investment Board raised its holdings in shares of IQVIA by 7.3% during the 1st quarter. Canada Pension Plan Investment Board now owns 4,594,831 shares of the medical research company's stock valued at $810,069,000 after purchasing an additional 312,807 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in IQVIA by 45.7% during the first quarter. JPMorgan Chase & Co. now owns 2,545,014 shares of the medical research company's stock valued at $448,686,000 after buying an additional 798,534 shares in the last quarter. Nordea Investment Management AB lifted its position in shares of IQVIA by 41.7% in the second quarter. Nordea Investment Management AB now owns 2,060,460 shares of the medical research company's stock worth $326,274,000 after buying an additional 606,391 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of IQVIA by 26.8% during the 1st quarter. American Century Companies Inc. now owns 1,438,995 shares of the medical research company's stock valued at $253,695,000 after acquiring an additional 304,258 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of IQVIA by 2.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,428,561 shares of the medical research company's stock valued at $251,852,000 after acquiring an additional 40,699 shares in the last quarter. 89.62% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on IQV shares. UBS Group lifted their price target on shares of IQVIA from $185.00 to $225.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Weiss Ratings reissued a "hold (c)" rating on shares of IQVIA in a research report on Saturday. Jefferies Financial Group raised IQVIA from a "hold" rating to a "buy" rating and raised their target price for the company from $195.00 to $225.00 in a report on Tuesday, September 9th. Truist Financial increased their price objective on IQVIA from $209.00 to $235.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Finally, Hsbc Global Res raised shares of IQVIA from a "hold" rating to a "strong-buy" rating in a research report on Thursday, October 9th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, IQVIA has an average rating of "Moderate Buy" and an average price target of $234.57.

IQVIA Trading Up 0.3%

Shares of IQV stock opened at $220.64 on Friday. The firm has a fifty day moving average of $194.47 and a 200-day moving average of $171.46. The stock has a market cap of $37.51 billion, a price-to-earnings ratio of 31.93, a P/E/G ratio of 2.42 and a beta of 1.32. IQVIA Holdings Inc. has a 52-week low of $134.65 and a 52-week high of $225.91. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.84 and a current ratio of 0.84.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.